The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage.

Hertle, Daniel N; Hähnel, Stefan; Richter, Götz M; Unterberg, Andreas; Sakowitz, Oliver W; Kiening, Karl L

Hertle, Daniel N; Hähnel, Stefan; Richter, Götz M; Unterberg, Andreas; Sakowitz, Oliver W; Kiening, Karl L.

Affiliation

Hertle DN; Department of Neurosurgery, Ruprecht-Karls-Universität, Heidelberg, Germany. daniel.hertle@med.uni-heidelberg.de

Br J Neurosurg ; 25(1): 117-9, 2011 Feb.

Article in En | MEDLINE | ID: mdl-20707682

Subject(s)

Anticoagulants/administration & dosage; Anticoagulants/adverse effects; Cerebral Hemorrhage/drug therapy; Chondroitin Sulfates/administration & dosage; Dermatan Sulfate/administration & dosage; Heparin, Low-Molecular-Weight/adverse effects; Heparitin Sulfate/administration & dosage; Aged; Blood Coagulation Disorders/drug therapy; Cerebral Hemorrhage/chemically induced; Chromosome Breakage; Chromosome Disorders/chemically induced; Chromosome Disorders/drug therapy; Humans; Male; Thrombocytopenia/chemically induced; Thrombocytopenia/congenital; Thrombocytopenia/drug therapy; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebral Hemorrhage / Chondroitin Sulfates / Heparin, Low-Molecular-Weight / Dermatan Sulfate / Heparitin Sulfate / Anticoagulants Limits: Aged / Humans / Male Language: En Journal: Br J Neurosurg Journal subject: NEUROCIRURGIA Year: 2011 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google